Abbott

YTD

ALL

Trade Abbott 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABT

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

CEO

Robert B. Ford

CEORobert B. Ford

Employees

115,000

Employees115,000

Headquarters

Abbott Park, Illinois

HeadquartersAbbott Park, Illinois

Founded

1888

Founded1888

Employees

115,000

Employees115,000

ABT Key Statistics

Market cap

158.94B

Market cap158.94B

Price-Earnings ratio

25.42

Price-Earnings ratio25.42

Dividend yield

2.67%

Dividend yield2.67%

Average volume

12.69M

Average volume12.69M

High today

$92.02

High today$92.02

Low today

$90.13

Low today$90.13

Open price

$90.73

Open price$90.73

Volume

14.11M

Volume14.11M

52 Week high

$139.06

52 Week high$139.06

52 Week low

$81.97

52 Week low$81.97

Stock Snapshot

With a market cap of 158.94B, Abbott(ABT) trades at $91.15. The stock has a price-to-earnings ratio of 25.42 and currently yields dividends of 2.7%.

On 2026-06-10, Abbott(ABT) stock moved within a range of $90.13 to $92.02. With shares now at $91.15, the stock is trading +1.1% above its intraday low and -0.9% below the session's peak.

Trading volume for Abbott(ABT) stock has reached 14.11M, versus its average volume of 12.69M.

The stock's 52-week range extends from a low of $81.97 to a high of $139.06.

ABT News

The Motley Fool 13h

New Investors: 3 Rock-Solid Stocks to Build Your Portfolio Around

If you're a new investor who's just getting started with investing, it can seem overwhelming trying to determine which stocks to buy. You may be tempted to go w...

TipRanks 2d

Abbott Buy Rating Reaffirmed as Analyst Sees Accelerating 2027 Earnings; $120 Price Target Maintained on Libre Duo Growth Potential

Abbott Laboratories, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Travis Steed from Bank of America Securities maintaine...

TipRanks 2d

Abbott announces new data on DKA for people with Type 1, Type 2 diabetes

Abbott (ABT) announced new data revealing diabetic ketoacidosis, DKA, “remains an important, yet often undetected health concern for people living with both Typ...

Analyst ratings

79%

of 29 ratings

Buy

79.3%

Hold

20.7%

Sell

More ABT News

Simply Wall St 3d

Abbott Laboratories Is Up 6.4% After European Approval of Dual Glucose‑Ketone Sensors

In late May and early June 2026, Abbott highlighted new data showing rising, often-missed diabetic ketoacidosis cases and secured CE Mark approval in Europe for...

Benzinga 5d

A Grandma Bought PediaSure To Help Her Grandson Grow — Now, Abbott Is In Federal Court

Judge Finds Marketing Could Be Interpreted As Promising Height Growth Citing a 75-page decision, Reuters report added that U.S. District Judge Paul Engelmayer...

People also own

Based on the portfolios of people who own ABT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.